期刊文献+

宫颈癌组织中人乳头瘤病毒16型E7基因的DNA改组

DNA Shuffling of HPV16 E7 gene in Cervical Cancer
下载PDF
导出
摘要 目的利用DNA改组技术进化人乳头瘤病毒16型E7(HPV16E7)基因,建立HPV16E7基因突变体库。方法从宫颈癌标本中扩增出HPV16E7基因,用脱氧核糖核酸酶(DNaseⅠ)碎片化该基因,切割成50 bp左右的小片段。这些小片段在不外加引物的条件下,利用PCR反应进行重聚,再将重聚物经过一轮普通PCR扩增。结果电泳切胶回收获得与原片段大小相当的基因片段,改组结果较为成功。结论DNA改组在HPV16E7改组中的应用并成功,有利于从HPV16E7基因突变题库中筛选出高免疫原性的基因型别,并为进一步构建HPV治疗性疫苗奠定基础。 Objective To utilize DNA shuffling for directed evolution of HPV16 E7 gene, and to construct the mutant library of HPV16 E7 gene. Methods HPV16 E7 gene was amplified by PCR from the samples of uterine cervix cancer and digested with DNase Ⅰ . Then the random fragments about 50 bp were purified and reassembled by PCR without primers, and the products were amplified by routine PCR. Results These 50-bp fragments were successfully reassembled to genes of the same size as HPV16 E7. Conclusion The successful DNA shuffling of HPV16 E7 gene in uterine cervical cance may help us screen the high immunogenicity of HPV16 E7 gene,which provides a basis for constructing the therapeutic vaccine for human papillomavirus.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2009年第6期420-422,共3页 Journal of China Medical University
基金 河北省自然科学基金资助项目(C2007000840)
关键词 人乳头瘤病毒16型E7基因 DNA改组 宫颈癌 人乳头瘤病毒疫苗 human papillomavirus 16 E7 gene DNA shuffling cervical cancer human papillomavirus vaccine
  • 相关文献

参考文献11

  • 1Clifford GM,Smith JS,Plummer M,et al . Human papillomavirus typesin invasive cervical cancer worldwide :a meta2 analysis [J ]. Br J Cancer, 2003,88 ( 1 ) : 63-73.
  • 2Cohen J. Pubic health. High hopes and dilemmas for a cervical can- cer vaccine [J]. Science, 2005,308( 5722 ) : 618-621.
  • 3Joura EA,Leodolter S,Hernandez-Avila M,et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6,11,16, and 18 ) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions:a combined analysis of three randomised clinical trials [J]. Lancet, 2007,369( 9574 ) : 1693-1702.
  • 4Stemmer WPC. DNA shuffling by random fragmentation and reassembly: lnvitro recombination formolecul are volution [ J ]. Proc NatlAcad Sci USA, 1994,91(22) : 10747 -10751.
  • 5Patten PA,Howard RJ,Stemmer WPC. Applications of DNA shuffling top harm- aceuticals and vaccines [J ].Curr Opin Biotechnol, 1997,8 ( 6 ) : 724-733.
  • 6Ocher CP, Soong NW,Whalen RG,et al. Development of novel vaccines using DNA shuffling and screening strategies [JJ. Curr Opin Mol Ther,2004,6 ( 1 ) :34-39.
  • 7Zur Hausen H. Papillomaviruses and cancer:frnm basic studies to clinical application [ J ]. Nat Rev Cancer, 2002,2 ( 5 ) : 342-350.
  • 8Hopfl R,Heim K,Christensen N,et al.Spontaneous regres-sion of CIN and delayed-type hypersenstivity to HPV-16 on coprotein ET[J]. Lancet, 2000,356( 9246 ) : 1985-19856.
  • 9Frazer IH, Quinn M, Nicklin JL, et al.Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adju rant in women with cervicalintraepithelial neoplasia [J].Vaccine, 2004,23(2) : 172-181.
  • 10Qian XL,Lu YZ,Liu Q,et al.Prophylactic,thera-peutic and antimetastatic effects of anHPV-16 mE6/mE7/TBhsp70 fusion protein vaccine in an animal model [ J ].Immunology Letters, 2006, 102 (2): 191-201.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部